Related Experiment Video
Updated: Jun 4, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardiorenal syndromes
Peter A McCullough1, Aftab Ahmad
1Peter A McCullough, Aftab Ahmad, Department of Medicine, Cardiology Section, St. John Providence Health System, Providence Park Hospital, Novi, MI 48374, United States.
Abstract:
Cardiorenal syndromes (CRS) have been subclassified as five defined entities which represent clinical circumstances in which both the heart and the kidney are involved in a bidirectional injury and dysfunction via a final common pathway of cell-to-cell death and accelerated apoptosis mediated by oxidative stress. Types 1 and 2 involve acute and chronic cardiovascular disease (CVD) scenarios leading to acute kidney injury or accelerated chronic kidney disease. Types 2 and 3 describe acute and chronic kidney disease leading primarily to heart failure, although it is possible that acute coronary syndromes, stroke, and arrhythmias could be CVD outcomes in these forms of CRS. Finally, CRS type 5 describes a simultaneous insult to both heart and kidneys, such as sepsis, where both organs are injured simultaneously. Both blood and urine biomarkers are reviewed in this paper and offer a considerable opportunity to enhance the understanding of the pathophysiology and known epidemiology of these recently defined syndromes.
Insights
Cardiorenal syndromes (CRS) involve bidirectional heart and kidney injury. This review explores five CRS types, their mechanisms, and the role of biomarkers in understanding these conditions.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Cardiorenal syndromes (CRS) are characterized by bidirectional injury between the heart and kidneys.
- Five distinct types of CRS have been defined, each involving specific pathways of cardiac and renal dysfunction.
- Oxidative stress and apoptosis are identified as common pathways in CRS pathogenesis.
Purpose of the Study:
- To review the classification and pathophysiology of the five defined types of cardiorenal syndromes.
- To explore the role of blood and urine biomarkers in understanding CRS.
- To enhance the comprehension of CRS epidemiology and underlying mechanisms.
Main Methods:
- Review of existing literature on cardiorenal syndromes.
- Analysis of the subclassification of CRS into five types.
- Examination of cellular mechanisms including cell-to-cell death and apoptosis.
- Discussion of biomarker utility in CRS.
Main Results:
- Cardiorenal syndromes are classified into five types based on the interplay between cardiac and renal dysfunction.
- Types 1 and 2 involve cardiovascular disease impacting the kidneys, while Types 3 and 4 involve kidney disease impacting the heart.
- Type 5 CRS represents simultaneous injury to both organs, as seen in sepsis.
- Biomarkers in blood and urine are crucial for understanding CRS pathophysiology and epidemiology.
Conclusions:
- The five types of cardiorenal syndromes provide a framework for understanding complex heart-kidney interactions.
- Oxidative stress and apoptosis are key mediators in the development of CRS.
- Biomarkers hold significant potential for improving the diagnosis, prognosis, and management of cardiorenal syndromes.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Diuretics
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
